Trends in disease-specific survival of head and neck squamous cell carcinoma patients treated in a single institution over a 30-year period-Reference-Cited by-同舟云学术

Trends in disease-specific survival of head and neck squamous cell carcinoma patients treated in a single institution over a 30-year period

Published:2021-04 Issue: Volume:115 Page:105184
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

León Xavier,Orús César,Casasayas María^ORCID,Neumann Eduard,Holgado Anna,Quer Miquel

Funder

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference20 articles.

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, MathersC, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.

2. www.redecan.es/redecan.org/es/Informe_incidencia_REDECAN_2020.pdf.

3. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database;Carvalho;Int J Cancer,2005

4. Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States;Gupta;Int J Cancer,2009

5. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis;Pulte;Oncologist,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of individualized home exercise programs for patients with head and neck cancer–study protocol and first results of a multicentre single-arm intervention trial (OSHO #94);PLOS ONE;2024-08-22

2. Feasibility of individualized home exercise programs for patients with head and neck cancer – study protocol and first results of a multicentre single-arm intervention trial (OSHO #94);2024-03-19

3. Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence;Oral Oncology;2023-08

4. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma;Scientific Reports;2023-07-22

5. Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction;Scientific Reports;2023-05-26